Omaha, Nebraska
Colorectal cancer clinical trials in Omaha, NE
27 colorectal cancer studies are recruiting participants at sites in Omaha as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Omaha at a glance
- 27 studies are recruiting at a site in Omaha.
- By phase: Phase 1 (4), Phase 1/2 (4), Phase 2 (4), Phase 2/3 (2), Phase 3 (6), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (18), university, hospital or other (9).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Omaha
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University Of Nebraska Medical Center ( Site 0078)
- Registry record
- NCT06997497 · updated
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study sites
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan · Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy · Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist
- Registry record
- NCT07750158 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Alegent Health Bergan Mercy Medical Center · Alegent Health Immanuel Medical Center · Alegent Health Lakeside Hospital
- Registry record
- NCT07018869 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Alegent Health Bergan Mercy Medical Center · Alegent Health Immanuel Medical Center · Alegent Health Lakeside Hospital
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Alegent Health Bergan Mercy Medical Center · Alegent Health Immanuel Medical Center · Alegent Health Lakeside Hospital
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Alegent Health Bergan Mercy Medical Center · Alegent Health Immanuel Medical Center · Alegent Health Lakeside Hospital
- Registry record
- NCT05334069 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Alegent Health Bergan Mercy Medical Center · Alegent Health Immanuel Medical Center · Alegent Health Lakeside Hospital
- Registry record
- NCT07283939 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Nebraska Medicine-Village Pointe · University of Nebraska Medical Center
- Registry record
- NCT05673148 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Nebraska Cancer Specialists Midwest Cancer Center
- Registry record
- NCT06662786 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT06750094 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Alegent Health Bergan Mercy Medical Center · Alegent Health Immanuel Medical Center · Alegent Health Lakeside Hospital
- Registry record
- NCT07143487 · updated
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT07416552 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT06710756 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646
- Registry record
- NCT06820463 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- University Of Nebraska Medical Center
- Registry record
- NCT07221357 · updated
Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of Nebraska
- Study site
- University of Nebraska Medical Center
- Registry record
- NCT05254327 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #2
- Registry record
- NCT05176483 · updated
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Radiopharm Theranostics, Ltd
- Study sites
- Nebraska Cancer Specialists · XCancer
- Registry record
- NCT07189871 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study sites
- Nebraska Cancer Specialists · University of Nebraska Medical Center
- Registry record
- NCT06445062 · updated
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Endevica Bio
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT06937177 · updated
Integrated Cancer Repository for Cancer Research
- Observational
- Ages 19 to 110
- All sexes
- Sponsor
- University of Nebraska
- Study sites
- Methodist Estabrook Cancer Center · Nebraska Methodist Health System · University of Nebraska Medical Center
- Registry record
- NCT02012699 · updated
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399
- Registry record
- NCT05005403 · updated
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Orano Med Theranostics, SAS
- Study sites
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy) · XCancer Omaha / Urology Cancer Center
- Registry record
- NCT05283330 · updated
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tasca Therapeutics
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT07030257 · updated
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT05855200 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Tempus AI
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT05234177 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Omaha, NE on ClinicalTrials.gov.
Ask about studies near Omaha
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections